KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and mining; energy and natural resources; financial services; healthcare; industrials; media and communications; retail; and technology. Within Europe, the firm invests in consumer and retail; energy; financial services; health care; industrials and chemicals; media and digital; and telecom and technologies. Within Asia, it invests in consumer products; energy and resources; financial services; healthcare; industrials; logistics; media and telecom; retail; real estate; and technology. It also seeks to make impact investments focused on identifying and investing behind businesses with positive social or environmental impact. The firm seeks to invest in mid to high-end residential developments, but can invest in other projects throughout Mainland China through outright ownership, joint ventures, and merger. It invests globally with a focus on Australia, emerging and developed Asia, Middle East and Africa, Nordic, Southeast Asia, Asia Pacific, Ireland, Hong Kong, Japan, Taiwan, India, Vietnam, Malaysia, Singapore, Indonesia, France, Germany, Netherlands, United Kingdom, Caribbean, Mexico, South America, North America, Brazil, Latin America, Korea with a focus on South Korea, and United States of America. In the United States and Europe, the firm focuses on buyouts of large, publicly traded companies. It seeks to invest $30 million to $717 million in companies with enterprise values between $500 million to $2389 million. The firm prefers to invest in a range of debt and public equity investing and may co-invest. It seeks a board seat in its portfolio companies and a controlling ownership of a company or a strategic minority positions. The firm may acquire majority and minority equity interests, particularly when making private equity investments in Asia or sponsoring investments as part of a large investor consortium. The firm typically holds its investment for a period of five to seven years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. KKR & Co. Inc. was founded in 1976 and is based in New York, New York with additional offices across North America, Europe, Australia, Sweden and Asia.
IPO Year:
Exchange: NYSE
Website: kkr.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities |
| 9/18/2024 | $148.00 | Buy | HSBC Securities |
| 9/12/2024 | $130.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $153.00 | Buy | Redburn Atlantic |
| 1/4/2024 | $96.00 | Outperform | TD Cowen |
| 11/30/2023 | $91.00 → $94.00 | Outperform | Oppenheimer |
| 10/5/2023 | $75.00 | Outperform | Wolfe Research |
| 5/19/2023 | $69.00 | Buy | Citigroup |
| 3/2/2023 | $69.00 | Overweight | Barclays |
| 11/2/2022 | $57.00 → $60.00 | Neutral → Buy | BofA Securities |
HSBC Securities downgraded KKR from Buy to Hold and set a new price target of $173.00
HSBC Securities initiated coverage of KKR with a rating of Buy and set a new price target of $148.00
Wells Fargo initiated coverage of KKR with a rating of Equal Weight and set a new price target of $130.00
Redburn Atlantic initiated coverage of KKR with a rating of Buy and set a new price target of $153.00
TD Cowen initiated coverage of KKR with a rating of Outperform and set a new price target of $96.00
Oppenheimer reiterated coverage of KKR with a rating of Outperform and set a new price target of $94.00 from $91.00 previously
Wolfe Research initiated coverage of KKR with a rating of Outperform and set a new price target of $75.00
Citigroup initiated coverage of KKR with a rating of Buy and set a new price target of $69.00
Barclays initiated coverage of KKR with a rating of Overweight and set a new price target of $69.00
BofA Securities upgraded KKR from Neutral to Buy and set a new price target of $60.00 from $57.00 previously
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
SC 13G/A - KKR & Co. Inc. (0001404912) (Subject)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
3 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
4 - KKR & Co. Inc. (0001404912) (Issuer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
CERT - KKR & Co. Inc. (0001404912) (Filer)
8-A12B - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
424B5 - KKR & Co. Inc. (0001404912) (Filer)
FWP - KKR & Co. Inc. (0001404912) (Subject)
424B5 - KKR & Co. Inc. (0001404912) (Filer)
S-8 - KKR & Co. Inc. (0001404912) (Filer)
10-K - KKR & Co. Inc. (0001404912) (Filer)
8-K - KKR & Co. Inc. (0001404912) (Filer)
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
Darwinbox, a leading global human resource ("HR") technology platform, today announced the signing of definitive agreements under which Partners Group, one of the largest firms in the global private markets industry (acting on behalf of its clients), and funds managed by KKR, a leading global investment firm, will co-lead an investment of $140 million in the company, with additional participation from Gravity Holdings. The addition of Partners Group and KKR to an already-solid cap-table underscores Darwinbox's strong momentum over the recent years. The investment positions Darwinbox well to deepen its technology leadership and accelerate its international expansion plans. This press release
Transaction marks significant outcome for KKR and poises Seiyu for further success KKR, a leading global investment firm, and Seiyu, a nationwide supermarket chain in Japan, today announced the signing of definitive agreements to sell Seiyu (the "Company") to Trial Holdings, Inc. (TSE stock code 141A; "Trial"), a distribution and retail business operator in Japan that operates a network of stores offering "everyday essentials" in Kyushu. This transaction represents a significant outcome for KKR and follows transformational work that positions Seiyu strongly for continued success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has priced its previously announced offering of $2.25 billion (45,000,000 shares) of its 6.25% Series D Mandatory Convertible Preferred Stock (the "mandatory convertible preferred stock") at a price to the public and liquidation preference of $50.00 per share. The offering was upsized from the previously announced size of $1.50 billion (30,000,000 shares). The underwriters have a 30-day option to purchase up to an additional $337.50 million (6,750,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. The offering is expected to close on March 7, 2025, subject to customary closing conditions.
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has commenced an offering of $1.5 billion (30,000,000 shares) of its Series D Mandatory Convertible Preferred Stock, par value $0.01 per share (the "mandatory convertible preferred stock"), subject to market and other conditions (the "offering"). KKR expects to grant the underwriters a 30-day option to purchase up to an additional $225 million (4,500,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. KKR intends to use the net proceeds from the offering for the acquisition of additional equity interests in core private equity portfolio companies reported in its Strategic Holdings segment a
MENLO PARK, Calif., March 4, 2025 /PRNewswire/ -- Ajax Health, a KKR-backed medical device platform, today announced the formation of a new entity, FlowMod. The new organization is the result of a collaboration between Boston Scientific Corporation, Ajax Health, and KKR, utilizing intellectual property developed by Boston Scientific. FlowMod intends to accelerate the creation, clinical validation, and regulatory approval for a system treating heart failure, a condition that affects pumping action of the heart muscles and currently impacts 64 million people worldwide.1 "On the
KKR, a leading global investment firm, and Family Doctor Pty Ltd. ("Family Doctor"), a leading group of general practitioner ("GP") clinics in Australia, today announced a bespoke financing solution by KKR (through funds managed by KKR) to Family Doctor. KKR's bespoke financing solution positions the Family Doctor to accelerate its growth and expansion, including through acquisitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250302805504/en/ Founded in 2008, Family Doctor provides comprehensive medical care services through its network of more than 110 GP-run clinics located in key metropolitan and regional areas across Au
PHILADELPHIA and NEW YORK, Feb. 26, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2024, and that its board of directors has declared a first quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2024(1) Net investment income of $0.61 per share, compared to $0.77 per share for the quarter ended September 30, 2024Adjusted net investment income(2) of $0.66 per share, compared to $0.74 per share for th
KKR to be the largest and controlling shareholder KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; "HCG"), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ("KKR") will become the largest shareholder in HCG and assume sole control of HCG's operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence. This press release features multimedia. View the full release here: https://www.businesswire.co
Becomes largest shareholder with 58% of ownership; to proceed with privatization KKR, a leading global investment firm, today announced that in connection with the two-stage tender offer (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED (TSE stock code 9749; "FUJI SOFT" or the "Company") through FK Co., Ltd. (the "Offeror"), the Offeror, an entity owned by investment funds managed by KKR, received tenders in excess of 19.25%, the minimum ownership stake required to conduct a squeeze-out (53.22% in total), and completed the second stage of its Tender Offer ("Second Tender Offer") on February 19, 2025. Upon settlement of the Second Tender Offer, includin
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has priced its previously announced offering of $2.25 billion (45,000,000 shares) of its 6.25% Series D Mandatory Convertible Preferred Stock (the "mandatory convertible preferred stock") at a price to the public and liquidation preference of $50.00 per share. The offering was upsized from the previously announced size of $1.50 billion (30,000,000 shares). The underwriters have a 30-day option to purchase up to an additional $337.50 million (6,750,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. The offering is expected to close on March 7, 2025, subject to customary closing conditions.
KKR & Co. Inc. ("KKR") (NYSE:KKR) today announced that it has commenced an offering of $1.5 billion (30,000,000 shares) of its Series D Mandatory Convertible Preferred Stock, par value $0.01 per share (the "mandatory convertible preferred stock"), subject to market and other conditions (the "offering"). KKR expects to grant the underwriters a 30-day option to purchase up to an additional $225 million (4,500,000 shares) of mandatory convertible preferred stock, solely to cover over-allotments, if any. KKR intends to use the net proceeds from the offering for the acquisition of additional equity interests in core private equity portfolio companies reported in its Strategic Holdings segment a
PHILADELPHIA and NEW YORK, Feb. 26, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK), or the Company, today announced its financial and operating results for the quarter and year ended December 31, 2024, and that its board of directors has declared a first quarter 2025 distribution of $0.70 per share. Financial and Operating Highlights for the Quarter Ended December 31, 2024(1) Net investment income of $0.61 per share, compared to $0.77 per share for the quarter ended September 30, 2024Adjusted net investment income(2) of $0.66 per share, compared to $0.74 per share for th
KKR to be the largest and controlling shareholder KKR, a leading global investment firm, and Healthcare Global Enterprises (BSE: 539787; NSE: HCG; "HCG"), a leading healthcare organization in India, today announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR ("KKR") will become the largest shareholder in HCG and assume sole control of HCG's operations. Dr. BS Ajaikumar, Founder of HCG, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence. This press release features multimedia. View the full release here: https://www.businesswire.co
Transaction marks KKR's latest technology growth investment in Australia SEEK Growth Fund continues to be a material investor in the company KKR, a leading global investment firm, Employment Hero, a global leader in employment management solutions, and SEEK Investments, manager of the SEEK Growth Fund, a long-term investment fund focused on human capital management, today announced the signing of definitive agreements under which funds managed by KKR will acquire a stake in Employment Hero ("the Company") from SEEK Investments. The SEEK Growth Fund continues to be a material investor in Employment Hero. This press release features multimedia. View the full release here: https://www.busine
Business combination materially improves scale and product scope, advancing Columbus McKinnon's strategy as the holistic provider of intelligent motion solutions in materials handlingComplementary portfolio enhances strategic positioning in attractive verticals and target geographies, delivering an even stronger portfolio of productsTransaction valued at approximately $2.7 billion at a ~8x TTM Adjusted EBITDA multiple post-synergiesExpected to create ~$70 million in annual net cost synergies, improving Adjusted EBITDA Margins1 to greater than 23% and is expected to more than double revenue and triple Adjusted EBITDA1 on a pro-forma combined basisSignificant combined cashflow generation expec
KKR & Co. Inc. (NYSE:KKR) today reported its fourth quarter 2024 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250204725162/en/ A conference call to discuss KKR's financial results will be held today, Tuesday, February 4, 2025 at 10:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Ce
KKR to become 12% common shareholder in Henry Schein Henry Schein and KKR to collaborate on range of value creation opportunities Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care, has joined the Henry Schein Board as an independent director Announces preliminary unaudited fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, and preliminary 2025 financial guidance for full-year non-GAAP EPS of low to mid single digit growth In addition, Henry Schein has increased its share repurchase progra
PHILADELPHIA and NEW YORK, Jan. 23, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its fourth quarter and full year 2024 results after the close of trading on the New York Stock Exchange on Wednesday, February 26, 2025. FSK will host its fourth quarter and full year 2024 results conference call via live webcast on Thursday, February 27, 2025 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the Investor Relations section of FSK's website at www.fskkradvisor.com under Events
KKR & Co. Inc. (NYSE:KKR) announced today that it has changed the date of its fourth quarter 2024 earnings conference call and webcast. The conference call will now be held on Tuesday, February 4, 2025 at 10:00 a.m. ET. The conference call was previously scheduled for Thursday, February 6, 2025. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Inve stor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be available on KKR's w
KKR & Co. Inc. (NYSE:KKR) today announced that Timothy R. Barakett has been appointed to the Board of Directors effective March 13, 2025. His appointment will bring the number of independent directors to ten out of a total of fourteen Board seats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313966947/en/Timothy R. Barakett (Photo: Business Wire) Mr. Barakett is the Founder and Chief Executive Officer of TRB Advisors, a private investment firm and family office. Prior to founding TRB Advisors in 2010, Mr. Barakett was the Founder and Chief Executive Officer of Atticus Capital, a global investment management firm. Mr. Baraket
The intelligent jobsite technology innovator secures record funding from KKR to expand data gathering and enrichment solutions. XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the acquisition of Specifx, an on-demand data enrichment and metadata retrieval platform for field service equipment. The acquisition was enabled by an investment from funds managed by leading global investment firm KKR. The funding from KKR marks the most significant milestone yet in XOi's journey to build out its system of work for the field service ecosystem. This press release features multimedia. View the full release here: https://www.businesswi
KKR, a leading global investment firm, today announced the appointment of Guy Metcalfe as Senior Advisor. In his role, Mr. Metcalfe will leverage his extensive real estate and capital markets expertise and relationship network around the world to support KKR's global real estate investment activity, platform growth and other strategic initiatives. Mr. Metcalfe previously served as Managing Director at Morgan Stanley and led its real estate investment banking business for over two decades before retiring as Global Chairman in 2024. Over his more than 30-year career at Morgan Stanley, Mr. Metcalfe was involved in more than $850 billion in transactions across multiple geographies including n
KKR Continues to Be Committed to FUJI SOFT's Privatization; Will Not Withdraw its Second Tender Offer KKR, a leading global investment firm, announced today that in connection with the Second Tender Offer in its two-stage tender offer scheme (the "Tender Offer") for the common shares and share options of FUJI SOFT INCORPORATED ("FUJI SOFT" or the "Company"; TSE stock code 9749) through FK Co., Ltd. (the "Offeror" or "FK Co."), an entity owned by investment funds managed by KKR, the Offeror has submitted an amendment statement to the Tender Offer Registration Statement that was submitted on November 20, 2024 (including the matters amended in the amendment statement to the Tender Offer Regi
Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date. Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growth and strengthened its position in the life sciences sector. Urs Spitz will remain a member of the Board of Directors. "We are grateful to Urs for his significant contributions in shaping Biosynth into the innovative and thriving compa
New leadership and reorganization will foster the next chapter of growth and enhance business operations to best support evolving client and CRO partner needs on a global scale. MALVERN, Pa., Oct. 29, 2024 /PRNewswire/ -- Resolian, a leading global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials, today announced several leadership changes as the company expands its global footprint and operational capabilities. Rob Stachlewitz will join Resolian as Chief Executive Officer (CEO), while current CEO Pat Bennett will transition into the newly created role of Chief Business Officer and President of Scientific Affairs. In addition, the
Global Atlantic Financial Group ("Global Atlantic"), a leading insurance provider meeting the retirement and life insurance needs of individuals and institutions, today announced the appointment of Tim Bridgers as Head of Preneed Sales, effective immediately. In this role, Mr. Bridgers will oversee all aspects of Global Atlantic's preneed sales, including agency and funeral home relationships, as well as strategies for marketing, pricing, and product development. He succeeds Kelly Milberger, who is retiring after a distinguished career in the industry. Based in Wilmington, North Carolina, Mr. Bridgers joins Global Atlantic from Live Oak Bank, where he spent a decade in various leadership
Announces Tim Moylan as Chief Commercial Officer; Appoints MercuryGate Chief Technology Officer (CTO) Beth Hendriks as CTO of Körber Supply Chain Software Körber Supply Chain Software, a joint venture between Körber AG and KKR, and leader in end-to-end supply chain solutions, today announced the completion of its acquisition of MercuryGate International Inc., a leading provider of transportation management systems (TMS). This milestone acquisition is one of the largest in the supply chain software industry this year, adding approximately 25 percent to Körber Supply Chain Software's annual net revenue. It significantly enhances Körber Supply Chain Software's vision for providing solutions
NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from the S
KKR, a leading global investment firm, today announced the signing of definitive agreements under which funds managed by KKR will acquire Healthium Medtech Ltd. ("Healthium"), a leading Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP ("Apax"), a leading global private equity advisory firm. The acquisition will be made by a special purpose vehicle owned by KKR-managed funds which will acquire a controlling interest in Healthium group, including Healthium. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240505117673/en/ Founded in India in 1992, Healthium is a medical devices company that dev